Usefulness of fibrosis markers in liver diseases
Iaquinto, G.; Maio, P.; Ambrosone, L.; Magliocca, M.; Taccone, W.; Imparato, L.; Rambaldi, M.
Italian Journal of Gastroenterology and Hepatology 30(2): 233-234
1998
ISSN/ISBN: 1125-8055 PMID: 9675667 Document Number: 488770
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Yamamoto, T.; Ikebe, T.; Takemura, S.; Shuto, T.; Kubo, S.; Hirohashi, K.; Kinoshita, H. 2004: Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver Hepato-Gastroenterology 51(57): 777-780Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681
Poynard, T. 2005: Surrogate markers for liver fibrosis Medical Journal of Malaysia 60 Suppl B: 39-40
Snarska, J.; Szajda, S.Dariusz.; Puchalski, Z.; Szmitkowski, M.; Chabielska, E.; Kaminski, F.; Zwierz, P.; Zwierz, K. 2006: Usefulness of examination of some tumor markers in diagnostics of liver cancer Hepato-Gastroenterology 53(68): 271-274
Guo, J.-X.; Ma, H.-B.; Li, Y.-L.; Xu, J.; Yang, L.-H.; Shi, J.-B.; Li, B.; Liu, A.-X.; Li, X.-X.; Li, B.-A.; Mao, Y.-L. 2009: Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(1): 71-73
Kryczka, W.ła.; Chrapek, M.; Zarebska-Michaluk, D. 2005: Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C Przeglad Epidemiologiczny 59(2): 395-403
Takashima, T.; Iijma, H.; Nishiguchi, S. 2015: Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF) Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 145-149
Kanoh, Y. 2011: Biochemical markers and physiological tests of atherosclerosis--changes and usefulness of markers in anti-atherosclerotic therapy Rinsho Byori. Japanese Journal of Clinical Pathology 59(1): 80-88
Schinoni, M.ía.I.; Paraná, R. 2006: Apoptosis and progression of hepatic fibrosis in liver diseases Acta Gastroenterologica Latinoamericana 36(4): 211-217
Johanet, C.; Abuaf, N.; Homberg, J.C. 1991: Markers of autoimmune liver diseases La Revue du Praticien 41(20): 1935-1939
Narang, A.P.; Mathur, V.S.; Koshy, A.; Nath, N.; Datta, D.V. 1981: Drug metabolism in non-cirrhotic portal fibrosis and other liver diseases Indian Journal of Medical Research 74: 266-272
Banciu, T.; Tudose, N. 1984: Morphological markers with predictive-evolutive value in liver diseases Medecine Interne 22(4): 297-301
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093
Mohamed, M.A.; Majda, E.; Mohamed, K.; Bechir, Z.; Sana, K.; Ehsène, B.B.; Samia, C. 2005: Do prothrombin time, transaminases, and platelet count predict the severity of fibrosis in viral liver diseases? La Tunisie Medicale 83(7): 400-403
Sugiyama, M.; Kanno, T.; Ohkubo, A.; Muto, Y.; Murata, K.; Ueno, Y. 1992: The clinical usefulness of the molar ratio of branched-chain amino acids to tyrosine (BTR) in discriminating stage of chronic liver diseases Rinsho Byori. Japanese Journal of Clinical Pathology 40(6): 673-678
Pár, A.; Luminita, S.; Erdósy, I.; Doru, D.; Kádas, I.; Paál, M.; Brasch, G.; Beró, T.; Jávor, T. 1992: Hepatitis virus (HBV, HCV, HDV) markers in chronic liver diseases. Comparative studies in two East-Central European countries Orvosi Hetilap 133(Suppl 1): 48-50
Loginov, A.S.; Bendikov, E.A.; Petrakov, A.V. 1995: Lipid peroxidation markers in the exhaled breath and microsomal oxidation in patients with chronic diffuse liver diseases Terapevticheskii Arkhiv 67(4): 50-53
Montes Santiago, J.; Gambón Deza, F.; García García, M.J.; González Vázquez, L.; Hermo Brión, J.A.; Pérez Alvarez, R. 2000: Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations Anales de Medicina Interna 17(7): 343-346
Gierczyński, R. 2000: Evaluation of the usefulness of selected virulence markers for identification of virulent strains of Yersinia enterocolitica strains. III. Chromosome markers of virulence Medycyna Doswiadczalna i Mikrobiologia 52(1): 51-65
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500